1
|
Oliveira M, Sousa A, Sá S, Soares S, Pereira AC, Rocha AC, Pais P, Ferreira D, Almeida C, Luís C, Lima C, Almeida F, Gestoso Á, Duarte MC, Barata P, Martins-Mendes D, Baylina P, Pereira CF, Fernandes R. Harvesting the Power of Green Synthesis: Gold Nanoparticles Tailored for Prostate Cancer Therapy. Int J Mol Sci 2024; 25:2277. [PMID: 38396953 PMCID: PMC10889744 DOI: 10.3390/ijms25042277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2024] [Revised: 01/26/2024] [Accepted: 02/09/2024] [Indexed: 02/25/2024] Open
Abstract
Biosynthetic gold nanoparticles (bAuNPs) present a promising avenue for enhancing bio-compatibility and offering an economically and environmentally responsible alternative to traditional production methods, achieved through a reduction in the use of hazardous chemicals. While the potential of bAuNPs as anticancer agents has been explored, there is a limited body of research focusing on the crucial physicochemical conditions influencing bAuNP production. In this study, we aim to identify the optimal growth phase of Pseudomonas aeruginosa cultures that maximizes the redox potential and coordinates the formation of bAuNPs with increased efficiency. The investigation employs 2,6-dichlorophenolindophenol (DCIP) as a redox indicator. Simultaneously, we explore the impact of temperature, pH, and incubation duration on the biosynthesis of bAuNPs, with a specific emphasis on their potential application as antitumor agents. Characterization of the resulting bAuNPs is conducted using ATR-FT-IR, TEM, and UV-Vis spectroscopy. To gain insights into the anticancer potential of bAuNPs, an experimental model is employed, utilizing both non-neoplastic (HPEpiC) and neoplastic (PC3) epithelial cell lines. Notably, P. aeruginosa cultures at 9 h/OD600 = 1, combined with biosynthesis at pH 9.0 for 24 h at 58 °C, produce bAuNPs that exhibit smaller, more spherical, and less aggregated characteristics. Crucially, these nanoparticles demonstrate negligible effects on HPEpiC cells while significantly impacting PC3 cells, resulting in reduced viability, migration, and lower IL-6 levels. This research lays the groundwork for the development of more specialized, economical, and ecologically friendly treatment modalities.
Collapse
Affiliation(s)
- Marco Oliveira
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - André Sousa
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
- FFCC-Facultad de Ciencias, University of Vigo, 36310 Vigo, Spain
| | - Sara Sá
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
- FFCC-Facultad de Ciencias, University of Vigo, 36310 Vigo, Spain
| | - Sílvia Soares
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Ana Cláudia Pereira
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Ana Catarina Rocha
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Patrick Pais
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- ECVA-UTAD, Escola de Ciências da Vida e do Ambiente, Universidade de Trás-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal
| | - Diogo Ferreira
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FFCC-Facultad de Ciencias, University of Vigo, 36310 Vigo, Spain
- TBIO, Center for Translational Health and Medical Biotechnology Research, ESS-IPP, Escola S. Saúde, Instituto Politécnico do Porto, 4200-465 Porto, Portugal
| | - Cátia Almeida
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Carla Luís
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Cláudio Lima
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Fábio Almeida
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Álvaro Gestoso
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Miguel-Correa Duarte
- FFCC-Facultad de Ciencias, University of Vigo, 36310 Vigo, Spain
- CINBIO, University of Vigo, 36310 Vigo, Spain
- Southern Galicia Institute of Health Research (IISGS), Biomedical Research Networking Center for Mental Health (CIBERSAM), 36310 Madrid, Spain
| | - Pedro Barata
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Daniela Martins-Mendes
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- FMUP, Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal
| | - Pilar Baylina
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
- TBIO, Center for Translational Health and Medical Biotechnology Research, ESS-IPP, Escola S. Saúde, Instituto Politécnico do Porto, 4200-465 Porto, Portugal
| | - Carla F. Pereira
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| | - Rúben Fernandes
- FP-I3ID, FP-BHS, Instituto de Investigação, Inovação e Desenvolvimento, Biomedical Health Sciences, Universidade Fernando Pessoa (UFP), 4249-004 Porto, Portugal
- CECLIN, Centro de Estudos Clínicos, Hospital Escola Fernando Pessoa, 4420-096 Gondomar, Portugal
- RISE-UFP, Rede de Investigação em Saúde, Universidade Fernando Pessoa, 4249-004 Porto, Portugal
- i3S, Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal
| |
Collapse
|
2
|
Veetil VT, Rajeeve AD, G.P S, Manish Kumar K, Bhagiyalakshmi M, Vinoba M, Yamuna R. β-Cyclodextrin capped ZnS nanoparticles for CER-assisted colorimetric and spectrophotometric detection of Pb 2⁺, Cu 2⁺, and Hg 2⁺ in an aqueous solution. Heliyon 2023; 9:e21850. [PMID: 38027943 PMCID: PMC10663911 DOI: 10.1016/j.heliyon.2023.e21850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Revised: 10/24/2023] [Accepted: 10/30/2023] [Indexed: 12/01/2023] Open
Abstract
Herein, simple, low-cost, and room-temperature synthesis of beta-cyclodextrin (β-CD) stabilized zinc sulfide nanoparticle (ZnS NP) through the chemical precipitation method has been reported for cation exchange reaction (CER) based colorimetric sensing of Pb2+, Cu2+, and Hg2+. Formation of β-CD stabilized ZnS NPs (ZnS@β-CD) was verified by physicochemical characterization techniques such as XRD, XPS, FE-SEM, and TEM. ZnS@β-CD NPs showed color change selectively for the metal ions Pb2⁺, Cu2⁺, and Hg2⁺ among the various metal ions including Sn2⁺, Cr³⁺, Mn2⁺, Fe³⁺, Co2⁺, Ni2⁺, and Cd2⁺. The solubility product of reactants and the transformed products are the reason for selective CER of ZnS@β-CD NPs towards Pb2⁺, Cu2⁺, and Hg2⁺ ions. ZnS@β-CD NPs dispersion revealed rapid color change from white to orange, black, and bright yellow on the addition of higher concentrations of Pb2⁺, Cu2⁺, and Hg2⁺ respectively. This color change is due to the formation of complete CER-transformed nanostructures such as PbS, CuS, and HgS in higher concentrations (10⁻1- 10⁻³ M) of corresponding metal ions. The partial CER altered products Zn1-x,PbxS, Zn1-xCuxS and Zn1-xHgxS were detected due to the appearance of pale color in the lower metal ions concentrations of 10⁻⁴ - 10⁻⁶ M. This CER assisted transformation was also monitored through spectrophotometric methods. Moreover, infrared spectroscopic analysis was used to testify the structure of CER transformed product. The synthesized ZnS@β-CD NPs act as an efficient CER-based sensor for distinguishing and determining Pb2⁺, Cu2⁺, and Hg2⁺ at different level concentrations in the aqueous solution.
Collapse
Affiliation(s)
- Vyshnavi T. Veetil
- Department of Sciences, Amrita School of Physical Sciences Coimbatore, Amrita Vishwa Vidyapeetham, India
- Bio-materials Chemistry Research Laboratory, Amrita School of Engineering Coimbatore, Amrita Vishwa Vidyapeetham, India
| | - Anakha D. Rajeeve
- Department of Sciences, Amrita School of Physical Sciences Coimbatore, Amrita Vishwa Vidyapeetham, India
- Bio-materials Chemistry Research Laboratory, Amrita School of Engineering Coimbatore, Amrita Vishwa Vidyapeetham, India
| | - Saran G.P
- Department of Sciences, Amrita School of Physical Sciences Coimbatore, Amrita Vishwa Vidyapeetham, India
- Bio-materials Chemistry Research Laboratory, Amrita School of Engineering Coimbatore, Amrita Vishwa Vidyapeetham, India
| | - K.S. Manish Kumar
- Department of Sciences, Amrita School of Physical Sciences Coimbatore, Amrita Vishwa Vidyapeetham, India
- Bio-materials Chemistry Research Laboratory, Amrita School of Engineering Coimbatore, Amrita Vishwa Vidyapeetham, India
| | - M. Bhagiyalakshmi
- Department of Chemistry, Central University of Kerala, Periye, Kerala 671316, India
| | - Mari Vinoba
- Petroleum Research Center, Kuwait Institute for Scientific Research, Safat 13109, Kuwait
| | - R. Yamuna
- Department of Sciences, Amrita School of Physical Sciences Coimbatore, Amrita Vishwa Vidyapeetham, India
- Bio-materials Chemistry Research Laboratory, Amrita School of Engineering Coimbatore, Amrita Vishwa Vidyapeetham, India
| |
Collapse
|
6
|
Quinson J, Aalling-Frederiksen O, Dacayan WL, Bjerregaard JD, Jensen KD, Jørgensen MRV, Kantor I, Sørensen DR, Theil Kuhn L, Johnson MS, Escudero-Escribano M, Simonsen SB, Jensen KMØ. Surfactant-Free Colloidal Syntheses of Gold-Based Nanomaterials in Alkaline Water and Mono-alcohol Mixtures. CHEMISTRY OF MATERIALS : A PUBLICATION OF THE AMERICAN CHEMICAL SOCIETY 2023; 35:2173-2190. [PMID: 36936178 PMCID: PMC10018736 DOI: 10.1021/acs.chemmater.3c00090] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/13/2023] [Revised: 02/10/2023] [Indexed: 06/18/2023]
Abstract
Gold nanoparticles (Au NPs) and gold-based nanomaterials combine unique properties relevant for medicine, imaging, optics, sensing, catalysis, and energy conversion. While the Turkevich-Frens and Brust-Schiffrin methods remain the state-of-the-art colloidal syntheses of Au NPs, there is a need for more sustainable and tractable synthetic strategies leading to new model systems. In particular, stabilizers are almost systematically used in colloidal syntheses, but they can be detrimental for fundamental and applied studies. Here, a surfactant-free synthesis of size-controlled colloidal Au NPs stable for months is achieved by the simple reduction of HAuCl4 at room temperature in alkaline solutions of low-viscosity mono-alcohols such as ethanol or methanol and water, without the need for any other additives. Palladium (Pd) and bimetallic Au x Pd y NPs, nanocomposites and multimetallic samples, are also obtained and are readily active (electro)catalysts. The multiple benefits over the state-of-the-art syntheses that this simple synthesis bears for fundamental and applied research are highlighted.
Collapse
Affiliation(s)
- Jonathan Quinson
- Department
of Chemistry, Copenhagen University, Universitetsparken 5, DK-2100 Copenhagen Ø, Denmark
- Biochemical
and Chemical Engineering Department, Aarhus
University, Åbogade 40, DK-8200 Aarhus, Denmark
| | | | - Waynah L. Dacayan
- Department
of Energy Conversion and Storage, Technical
University of Denmark, Fysikvej Building 310, DK-2800 Kgs. Lyngby, Denmark
| | - Joachim D. Bjerregaard
- Department
of Chemistry, Copenhagen University, Universitetsparken 5, DK-2100 Copenhagen Ø, Denmark
| | - Kim D. Jensen
- Department
of Chemistry, Copenhagen University, Universitetsparken 5, DK-2100 Copenhagen Ø, Denmark
| | - Mads R. V. Jørgensen
- Department
of Chemistry and iNANO, Aarhus University, Langelandsgade 140, DK-8000 Aarhus C, Denmark
- MAX
IV Laboratory, Lund University, Fotongatan 2, SE-224 84 Lund, Sweden
| | - Innokenty Kantor
- MAX
IV Laboratory, Lund University, Fotongatan 2, SE-224 84 Lund, Sweden
- Department
of Physics, The Technical University of
Denmark, Fysikvej Building
311, DK-2800 Kgs.
Lyngby, Denmark
| | - Daniel R. Sørensen
- Department
of Chemistry and iNANO, Aarhus University, Langelandsgade 140, DK-8000 Aarhus C, Denmark
- MAX
IV Laboratory, Lund University, Fotongatan 2, SE-224 84 Lund, Sweden
| | - Luise Theil Kuhn
- Department
of Energy Conversion and Storage, Technical
University of Denmark, Fysikvej Building 310, DK-2800 Kgs. Lyngby, Denmark
| | - Matthew S. Johnson
- Department
of Chemistry, Copenhagen University, Universitetsparken 5, DK-2100 Copenhagen Ø, Denmark
| | - María Escudero-Escribano
- Department
of Chemistry, Copenhagen University, Universitetsparken 5, DK-2100 Copenhagen Ø, Denmark
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, UAB Campus, Bellaterra, 08193 Barcelona, Spain
- ICREA, Passeig de Lluís Companys,
23, 08010 Barcelona, Spain
| | - Søren B. Simonsen
- Department
of Energy Conversion and Storage, Technical
University of Denmark, Fysikvej Building 310, DK-2800 Kgs. Lyngby, Denmark
| | - Kirsten M. Ø. Jensen
- Department
of Chemistry, Copenhagen University, Universitetsparken 5, DK-2100 Copenhagen Ø, Denmark
| |
Collapse
|